Literature DB >> 32445244

Regular sweating activities for the treatment of cholinergic urticaria with or without acquired idiopathic generalized anhidrosis.

Tomoyuki Minowa1, Yasuyuki Sumikawa1, Yuji Kan1, Takafumi Kamiya1, Hisashi Uhara1.   

Abstract

Cholinergic urticaria (CholU) decreases affected individuals' quality of life because they must avoid stimuli including exercise and hot bathing. Although case reports have indicated that regular sweating activities are effective for CholU with hypohidrosis, little evidence is available. This retrospective medical record review examined CholU patients who received any form of treatment at our hospital. Twenty-seven cases (78% men; median age 22 years, range 12-70 years) were analyzed. Fourteen (52%) patients had acquired idiopathic generalized anhidrosis (AIGA). Among the 12 patients receiving sweating therapy (4 with, 8 without AIGA), improvement of symptoms was confirmed in 11 (92%; sweating therapy alone: n = 5, with H1 blocker: n = 5, with steroid pulse: n = 1) including 8 (67%) showing complete response (CR). In this sweating-therapy group, CR was achieved by six of the eight (75%) patients without AIGA and two of the four (50%) patients with AIGA. Among the 15 patients without sweating therapy, symptom improvement was observed in 9 (60%; steroid pulse: n = 7, H1 blocker: n = 2) including 1 (7%) achieving CR. Sweating therapy was safely undertaken except in one case in which the patient showed angioedema and anaphylaxis. Regular sweating activities could be a potential therapeutic option for CholU patients.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  acquired idiopathic generalized anhidrosis; bath; cholinergic urticaria; exercise; sweating

Mesh:

Substances:

Year:  2020        PMID: 32445244     DOI: 10.1111/dth.13647

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  2 in total

1.  Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.

Authors:  Yiyu Wang; Jörg Scheffel; Carolina Ayala Vera; Wei Liu; Dorothee Günzel; Dorothea Terhorst-Molawi; Marcus Maurer; Sabine Altrichter
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 2.  Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Shinya Imamura; Mayuko Mizuno; Takeshi Fukumoto; Ken Washio
Journal:  Am J Clin Dermatol       Date:  2022-09-15       Impact factor: 6.233

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.